Thinking Big, Thinking Small
Research Shows Genetic Links in ANCA-Associated Vasculitis
AAV Remission Study: Does Rituximab or Azathioprine Work Best?
Rituximab Maintenance Study: Is Fixed-Schedule or Tailored Dosing Best?
ANCA-Associated Vasculitis Pathogenesis & Treatment Updates
Changes in BMI Associated with Improvements in Disease Activity & Glucocorticoid Treatment
Malignancy Risk in ANCA-Associated Vasculitis Is Lower with Rituximab
Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
